These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7188752)

  • 1. The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behavior.
    Moon BH; Feigenbaum JJ; Carson PE; Klawans HL
    Eur J Pharmacol; 1980 Jan; 61(1):71-8. PubMed ID: 7188752
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone blockade of apomorphine-induced stereotyped behavior: interaction of endogenous opiates with dopamine.
    Margolin DI; Moon BH
    J Neurol Sci; 1979 Sep; 43(1):13-7. PubMed ID: 574897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
    Shintomi K; Yamamura M
    Eur J Pharmacol; 1975 Apr; 31(2):273-80. PubMed ID: 1171014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of apomorphine-induced rotational behaviour by naloxone.
    Quock RM; Welsh TB
    J Pharm Pharmacol; 1981 Feb; 33(2):111-3. PubMed ID: 6111591
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
    Extein I; Lo C; Goodwin FK; Schoenfeld RI
    Psychiatry Res; 1979 Dec; 1(3):333-9. PubMed ID: 233159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration.
    Heal DJ; Green AR; Buylaert WA
    Neuropharmacology; 1980 Jan; 19(1):133-7. PubMed ID: 6102352
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent effects of morphine and apomorphine on stereotyped gnawing in the hamster.
    Schnur P; Martinez RA
    Pharmacol Biochem Behav; 1989 Mar; 32(3):589-94. PubMed ID: 2662220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of naloxone in laboratory tests predictive of clinical antipsychotic activity.
    Malick JB; Billingsley ML; Kubena RK; Goldstein JM
    Commun Psychopharmacol; 1977; 1(5):475-88. PubMed ID: 23920
    [No Abstract]   [Full Text] [Related]  

  • 11. Is morphine-induced catalepsy related to activation of dopaminergic neurones?
    Moleman P; Versluis DJ; Bruinvels J
    Psychopharmacology (Berl); 1978 Dec; 60(1):35-9. PubMed ID: 104343
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible role of dopamine in central effects of cocaine as measured by apomorphine gnawing test in mice.
    Dadkar NK; Dohadwalla AN; Bhattacharya BK
    Psychopharmacology (Berl); 1977 Apr; 52(2):115-7. PubMed ID: 407594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
    Buckett WR; Shaw JS
    Psychopharmacologia; 1975 Jun; 42(3):293-7. PubMed ID: 1172254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: possible involvement of dopamine.
    Hine B; Friedman E; Torrelio M; Gershon S
    Neuropharmacology; 1975 Aug; 14(8):607-10. PubMed ID: 1237098
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency.
    Ljungberg T; Ungerstedt U
    Psychopharmacology (Berl); 1979 Feb; 60(3):303-7. PubMed ID: 108708
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.